164
Views
18
CrossRef citations to date
0
Altmetric
Review

The use of glutathione transferase-knockout mice as pharmacological and toxicological models

Pages 421-433 | Published online: 31 May 2007

Bibliography

  • THOMAS KR, CAPECCHI MR: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell (1987) 51(3):503-512.
  • MANNERVIK B, DANIELSON UH: Glutathione transferases – structure and catalytic activity. CRC Crit. Rev. Biochem. (1988) 23(3):283-337.
  • HAYES JD, FLANAGAN JU, JOWSEY IR: Glutathione transferases. Ann. Rev. Pharmacol. Toxicol. (2005) 45:51-88.
  • HENDERSON CJ, WOLF CR, KITTERINGHAM N et al.: Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase π. Proc. Natl. Acad. Sci. USA (2000) 97(23):12741-12745.
  • FERNANDEZ-CANON JM, BAETSCHER MW, FINEGOLD M et al.: Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol. Cell. Biol. (2002) 22(13):4943-4951.
  • LIM CE, MATTHAEI KI, BLACKBURN AC et al.: Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am. J. Pathol. (2004) 165(2):679-693.
  • ENGLE MR, SINGH SP, CZERNIK PJ et al.: Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol. Appl. Pharmacol. (2004) 194(3):296-308.
  • CHOWDHURY UK, ZAKHARYAN RA, HERNANDEZ A et al.: Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol. Appl. Pharmacol. (2006) 216(3):446-457.
  • FUJIMOTO K, ARAKAWA S, SHIBAYA Y et al.: Characterization of phenotypes in Gstm1-null mice by cytosolic and in vivo metabolic studies using 1,2-dichloro-4-nitrobenzene. Drug Metab. Dispos. (2006) 34(9):1495-1501.
  • ISHIKAWA T: The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. (1992) 17(11):463-468.
  • LITWACK G, KETTERER B, ARIAS IM: Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature (1971) 234(5330):466-467.
  • MANNERVIK B, WIERDERSTEN M: Human glutathione transferases: classification, tissue distribution, structure and functional properties. In: Advances in drug metabolism in man. Pacifici GM, Fracchia GN (Eds), The European Commission, Brussels, Belgium (1995):407-460.
  • JOHANSSON AS, MANNERVIK B: Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J. Biol. Chem. (2001) 276(35):33061-33065.
  • BOARD PG, TAYLOR MC, COGGAN M et al.: Clarification of the role of key active site residues of glutathionetransferase Zeta/maleylacetoacetate isomerase by a new spectrophotometric technique. Biochem. J. (2003) 374(Pt 3):731-737.
  • ADLER V, YIN Z, FUCHS SY et al.: Regulation of JNK signaling by GSTp. EMBO J. (1999) 18(5):1321-1334.
  • CHO SG, LEE YH, PARK HS et al.: Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. (2001) 276(16):12749-12755.
  • WU Y, FAN Y, XUE B et al.: Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 25(42):5787-5800.
  • DULHUNTY A, GAGE P, CURTIS S, CHELVANAYAGAM G, BOARD P: The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem. (2001) 276(5):3319-3323.
  • CROMER BA, MORTON CJ, BOARD PG, PARKER MW: From glutathione transferase to pore in a CLIC. Eur. Biophys. J. (2002) 31(5):356-364.
  • HARROP SJ, DEMAERE MZ, FAIRLIE WD et al.: Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution. J. Biol. Chem. (2001) 276(48):44993-45000.
  • SHIELD AJ, MURRAY TP, BOARD PG: Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase. Biochem. Biophys. Res. Commun. (2006) 347(4):859-866.
  • MANNERVIK B, AWASTHI YC, BOARD PG et al.: Nomenclature for human glutathione transferases [letter]. Biochem. J. (1992) 282(Pt 1):305-306.
  • MANNERVIK B, BOARD PG, HAYES JD, LISTOWSKY I, PEARSON WR: Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol. (2005) 401:1-8.
  • BOARD PG: Biochemical genetics of glutathione-S-transferase in man. Am. J. Hum. Genet. (1981) 33(1):36-43.
  • WARHOLM M, GUTHENBERG C, MANNERVIK B, VON BAHR C, GLAUMANN H: Identification of a new glutathione S-transferase in human liver. Acta Chem. Scand. B (1980) 34(8):607-621.
  • SEIDEGARD J, DEPIERRE JW, PERO RW: Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbene oxide in resting human mononuclear leukocytes are due to a particular isozyme(s). Carcinogenesis (1985) 6(8):1211-1216.
  • SEIDEGARD J, VORACHEK WR, PERO RW, PEARSON WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA (1988) 85(19):7293-7297.
  • SEIDEGARD J, PERO RW, STILLE B: Identification of the trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes and in liver as GST1. Biochem. Genet. (1989) 27(3-4):253-261.
  • WARHOLM M, GUTHENBERG C, MANNERVIK B: Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry (1983) 22(15):3610-3617.
  • HALL AG, AUTZEN P, CATTAN AR et al.: Expression of mu class glutathione S-transferase correlates with event- free survival in childhood acute lymphoblastic leukemia. Cancer Res. (1994) 54(20):5251-5254.
  • ROCHA JC, CHENG C, LIU W et al.: Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood (2005) 105(12):4752-4758.
  • LAYTON MA, JONES PW, ALLDERSEA JE et al.: The therapeutic response to d-penicillamine in rheumatoid arthritis: influence of glutathione S-transferase polymorphisms. Rheumatology (Oxford) (1999) 38(1):43-47.
  • ROY B, CHOWDHURY A, KUNDU S et al.: Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 ‘null’ mutation. J. Gastroenterol. Hepatol. (2001) 16(9):1033-1037.
  • PEMBLE S, SCHROEDER KR, SPENCER SR et al.: Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. (1994) 300(Pt 1):271-276.
  • CHENEVIX-TRENCH G, YOUNG J, COGGAN M, BOARD P: Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis (1995) 16(7):1655-1657.
  • THIER R, TAYLOR JB, PEMBLE SE et al.: Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA-1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl. Acad. Sci. USA (1993) 90(18):8576-8580.
  • NAOE T, TAGAWA Y, KIYOI H et al.: Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy. Leukemia (2002) 16(2):203-208.
  • PEARSON WR: Phylogenies of glutathione transferase families. Methods Enzymol. (2005) 401:186-204.
  • BOARD PG: Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4- 4. Biochem. J. (1998) 330(Pt 2):827-831.
  • ZIMNIAK P, SINGHAL SS, SRIVASTAVA SK et al.: Estimation of genomic complexity, heterologous expression, and enzymatic characterization of mouse glutathione S-transferase mGSTA4-4 (GST 5.7). J. Biol. Chem. (1994) 269(2):992-1000.
  • JOHANSSON AS, MANNERVIK B: Active-site residues governing high steroid isomerase activity in human glutathione transferase A3-3. J. Biol. Chem. (2002) 277(19):16648-16654.
  • COLES BF, ANDERSON KE, DOERGE DR et al.: Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res. (2000) 60(3):573-579.
  • HENDERSON CJ, WOLF CR: Disruption of the glutathione transferase pi class genes. Methods Enzymol. (2005) 401:116-135.
  • HATAYAMA I, SATOH K, SATO K: Developmental and hormonal regulation of the major form of hepatic glutathione S-transferase in male mice. Biochem. Biophys. Res. Commun. (1986) 140(2):581-588.
  • SHARMA R, AHMAD H, SINGHAL SS et al.: Comparative studies on the effect of butylated hydroxyanisole on glutathione and glutathione S-transferases in the tissues of male and female CD-1 mice. Comp. Biochem. Physiol. C (1993) 105(1):31-37.
  • BLACKBURN AC, MATTHAEI KI, LIM CE et al.: Deficiency of glutathione transferase Zeta causes oxidative stress and activation of antioxidant response pathways. Mol. Pharmacol. (2006) 69(2):650-657.
  • CHANAS SA, JIANG Q, MCMAHON M et al.: Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. (2002) 365(Pt 2):405-416.
  • SUZUKI T, COGGAN M, SHAW DC, BOARD PG: Electrophoretic and immunological analysis of human glutathione S-transferase isozymes. Ann. Hum. Genet. (1987) 51(Pt 2):95-106.
  • MOFFAT GJ, MCLAREN AW, WOLF CR: Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human pi-class glutathione S-transferase gene. Biochem. J. (1997) 324(Pt 1):91-95.
  • HAYES PC, HARRISON DJ, BOUCHIER IA, MCLELLAN LI, HAYES JD: Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium. Gut (1989) 30(6):854-859.
  • STRANGE RC, JOHNSON PH, LAWTON A et al.: Studies on the variability of glutathione S-transferase from human erythrocytes. Clin. Chim. Acta (1982) 120(2):251-260.
  • LEE WH, MORTON RA, EPSTEIN JI et al.: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA (1994) 91(24):11733-11737.
  • GUTHENBERG C, AKERFELDT K, MANNERVIK B: Purification of glutathione-S-transferase from human placenta. Acta Chem. Scand. B (1979) 33(8):595-596.
  • MARCUS CJ, HABIG WH, JAKOBY WB: Glutathione transferase from human erythrocytes. Nonidentity with the enzymes from liver. Arch. Biochem. Biophys. (1978) 188(2):287-293.
  • BOARD PG, WEBB GC, COGGAN M: Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann. Hum. Genet. (1989) 53(Pt 3):205-213.
  • HARRIS MJ, COGGAN M, LANGTON L, WILSON SR, BOARD PG: Polymorphism of the π class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics (1998) 8(1):27-31.
  • HU X, XIA H, SRIVASTAVA SK et al.: Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. (1997) 238(2):397-402.
  • HARRIES LW, STUBBINS MJ, FORMAN D, HOWARD GC, WOLF CR: Identification of genetic polymorphisms at the glutathione S-transferase π locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 18(4):641-644.
  • DALHOFF K, BUUS JENSEN K, ENGHUSEN POULSEN H: Cancer and molecular biomarkers of Phase II. Methods Enzymol. (2005) 400:618-627.
  • MENEGON A, BOARD PG, BLACKBURN AC, MELLICK GD, LE COUTEUR DG: Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet (1998) 352(9137):1344-1346.
  • FRYER AA, BIANCO A, HEPPLE M et al.: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. (2000) 161(5):1437-1442.
  • AYNACIOGLU AS, NACAK M, FILIZ A, EKINCI E, ROOTS I: Protective role of glutathione S-transferase P1 (GSTP1) Val105Val genotype in patients with bronchial asthma. Br. J. Clin. Pharmacol. (2004) 57(2):213-217.
  • HENRION-CAUDE A, FLAMANT C, ROUSSEY M et al.: Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology (2002) 36(4 Pt 1):913-917.
  • BAMMLER TK, SMITH CA, WOLF CR: Isolation and characterization of two mouse pi-class glutathione S-transferase genes. Biochem. J. (1994) 298(Pt 2):385-390.
  • HENDERSON CJ, SMITH AG, URE J et al.: Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. USA (1998) 95(9):5275-5280.
  • ANKER AL, SMILKSTEIN MJ: Acetaminophen. Concepts and controversies. Emerg. Med. Clin. North Am. (1994) 12(2):335-349.
  • PATTEN CJ, THOMAS PE, GUY RL et al.: Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. (1993) 6(4):511-518.
  • NIITSU Y, TAKAYAMA T, MIYANISHI K et al.: Implication of GST-pi expression in colon carcinogenesis. Chem. Biol. Interact. (2001) 133:287-290.
  • ADACHI J, HASEGAWA M: Model of amino acid substitution in proteins encoded by mitochondrial DNA. J. Mol. Evol. (1996) 42(4):459-468.
  • NOBUOKA A, TAKAYAMA T, MIYANISHI K et al.: Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. Gastroenterology (2004) 127(2):428-443.
  • ELSBY R, KITTERINGHAM NR, GOLDRING CE et al.: Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase π. J. Biol. Chem. (2003) 278(25):22243-22249.
  • ESTERBAUER H, SCHAUR RJ, ZOLLNER H: Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. (1991) 11(1):81-128.
  • POLI G, SCHAUR RJ: 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life (2000) 50(4-5):315-321.
  • BOARD PG, WEBB GC: Isolation of a cDNA clone and localization of human glutathione S-transferase 2 genes to chromosome band 6p12. Proc. Natl. Acad. Sci. USA (1987) 84(8):2377-2381.
  • CZOSNEK H, SARID S, BARKER PE, RUDDLE FH, DANIEL V: Glutathione S-transferase Ya subunit is coded by a multigene family located on a single mouse chromosome. Nucleic Acids Res. (1984) 12(12):4825-4833.
  • LE COUTEUR DG, MCLEAN AJ, TAYLOR MC, WOODHAM BL, BOARD PG: Pesticides and Parkinson’s disease. Biomed. Pharmacother. (1999) 53(3):122-130.
  • DWIVEDI S, SHARMA R, SHARMA A et al.: The course of CCl4 induced hepatotoxicity is altered in mGSTA4-4 null (-/-) mice. Toxicology (2006) 218(1):58-66.
  • LI J, SHARMA R, PATRICK B et al.: Regulation of CD95 (Fas) expression and Fas-mediated apoptotic signaling in HLE B-3 cells by 4-hydroxynonenal. Biochemistry (2006) 45(40):12253-12264.
  • BOARD PG, BAKER RT, CHELVANAYAGAM G, JERMIIN LS: Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem. J. (1997) 328(Pt 3):929-935.
  • FERNANDEZ-CANON JM, PENALVA MA: Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J. Biol. Chem. (1998) 273(1):329-337.
  • TONG Z, BOARD PG, ANDERS MW: Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. (1998) 331(Pt 2):371-374.
  • TONG Z, BOARD PG, ANDERS MW: Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other α-haloacids. Chem. Res. Toxicol. (1998) 11(11):1332-1338.
  • STACPOOLE PW, HENDERSON GN, YAN Z, JAMES MO: Clinical pharmacology and toxicology of dichloroacetate. Environ. Health Perspect. (1998) 106(Suppl. 4):989-994.
  • BULL RJ, SANCHEZ IM, NELSON MA, LARSON JL, LANSING AJ: Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology (1990) 63(3):341-359.
  • DEANGELO AB, DANIEL FB, MOST BM, OLSON GR: The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology (1996) 114(3):207-221.
  • KRASNER SW, MCGUIRE MJ, JACANGELO JG et al.: The occurence of disinfection by-products in US drinking water. J. Am. Water Works Assoc. (1989) 81:41-53.
  • BONNET S, ARCHER SL, ALLALUNIS-TURNER J et al.: A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell (2007) 11(1):37-51.
  • BLACKBURN AC, WOOLLATT E, SUTHERLAND GR, BOARD PG: Characterization and chromosome location of the gene GSTZ1 encoding the human zeta class glutathione transferase and maleylacetoacetate isomerase. Cytogenet. Cell Genet. (1998) 83(1-2):109-114.
  • BLACKBURN AC, COGGAN M, TZENG HF et al.: GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase. Pharmacogenetics (2001) 11(8):671-678.
  • GROMPE M: The pathophysiology and treatment of hereditary tyrosinemia Type 1. Semin. Liver Dis. (2001) 21(4):563-571.
  • TZENG HF, BLACKBURN AC, BOARD PG, ANDERS MW: Polymorphism- and species-dependent inactivation of glutathione transferase ζ by dichloroacetate. Chem. Res. Toxicol. (2000) 13(4):231-236.
  • BOARD PG, SUZUKI T, SHAW DC: Human muscle glutathione S-transferase (GST-4) shows close homology to human liver GST-1. Biochim. Biophys. Acta (1988) 953(3):214-217.
  • BOARD PG, COGGAN M, CHELVANAYAGAM G et al.: Identification, characterization and crystal structure of the omega class glutathione transferases. J. Biol. Chem. (2000) 275(32):24798-24806.
  • WHITBREAD AK, MASOUMI A, TETLOW N et al.: Characterization of the omega class of glutathione transferases. Methods Enzymol. (2005) 401:78-99.
  • BOARD PG, ANDERS MW: Glutathione transferase omega 1 catalyzes the reduction of S-(phenacyl)glutathiones to acetophenones. Chem. Res. Toxicol. (2007) 20(1):149-154.
  • WHITBREAD AK, TETLOW N, EYRE HJ, SUTHERLAND GR, BOARD PG: Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics (2003) 13(3):131-144.
  • SCHMUCK EM, BOARD PG, WHITBREAD AK et al.: Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer’s and Parkinson’s diseases. Pharmacogenet. Genomics (2005) 15(7):493-501.
  • MARNELL LL, GARCIA-VARGAS GG, CHOWDHURY UK et al.: Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem. Res. Toxicol. (2003) 16(12):1507-1513.
  • ROJEWSKI MT, KORPER S, SCHREZENMEIER H: Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside. Leuk. Lymphoma (2004) 45(12):2387-2401.
  • HU J, FANG J, DONG Y, CHEN SJ, CHEN Z: Arsenic in cancer therapy. Anti-Cancer Drugs (2005) 16(2):119-127.
  • WESTERVELT P, BROWN RA, ADKINS DR et al.: Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood (2001) 98(2):266-271.
  • ZAKHARYAN RA, SAMPAYO-REYES A, HEALY SM et al.: Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. (2001) 14(8):1051-1057.
  • LALIBERTE RE, PERREGAUX DG, HOTH LR et al.: Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing. J. Biol. Chem. (2003) 278(19):16567-16578.
  • TRIVEDI SG, NEWSON J, RAJAKARIAR R et al.: Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc. Natl. Acad. Sci. USA (2006) 103(13):5179-5184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.